BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29025425)

  • 1. Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer.
    Chan AT; Plodkowski AJ; Pun SC; Lakhman Y; Halpenny DF; Kim J; Goldburg SR; Matasar MJ; Moskowitz CS; Gupta D; Steingart R; Weinsaft JW
    J Cardiovasc Magn Reson; 2017 Oct; 19(1):76. PubMed ID: 29025425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses.
    Chan AT; Maya TR; Park C; Tak K; Liberman N; Jain RH; Park MJ; Park RY; Grizzard J; Kim G; Tap WD; Jessurun J; Liu J; Kim J; Steingart RM; Weinsaft JW
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):128-145. PubMed ID: 37410010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity.
    Chan AT; Dinsfriend W; Kim J; Yum B; Sultana R; Klebanoff CA; Plodkowski A; Perez Johnston R; Ginsberg MS; Liu J; Kim RJ; Steingart R; Weinsaft JW
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):42. PubMed ID: 33814005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
    Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern and Prognostic Implications of Cardiac Metastases Among Patients With Advanced Systemic Cancer Assessed With Cardiac Magnetic Resonance Imaging.
    Pun SC; Plodkowski A; Matasar MJ; Lakhman Y; Halpenny DF; Gupta D; Moskowitz C; Kim J; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study.
    Velangi PS; Choo C; Chen KA; Kazmirczak F; Nijjar PS; Farzaneh-Far A; Okasha O; Akçakaya M; Weinsaft JW; Shenoy C
    Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009723. PubMed ID: 31707810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
    Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
    JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
    Stevenson A; Bray JJH; Tregidgo L; Ahmad M; Sharma A; Ng A; Siddiqui A; Khalid AA; Hylton K; Ionescu A; Providencia R; Kirresh A
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):345-357. PubMed ID: 36752432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility and clinical implication of late gadolinium enhancement cardiac magnetic resonance for detection of catheter associated right atrial thrombus.
    Plodkowski AJ; Chan A; Gupta D; Lakhman Y; Kukar N; Kim J; Perez-Johnston R; Ginsberg MS; Steingart RM; Weinsaft JW
    Clin Imaging; 2020 Jun; 62():17-22. PubMed ID: 32036237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognostic value of right ventricular (dys)function in patients with non-ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging.
    Becker MAJ; van der Lingen ACJ; Wubben M; van de Ven PM; van Rossum AC; Cornel JH; Allaart CP; Germans T
    ESC Heart Fail; 2021 Apr; 8(2):1055-1063. PubMed ID: 33560582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
    Zhang Q; Burrage MK; Lukaschuk E; Shanmuganathan M; Popescu IA; Nikolaidou C; Mills R; Werys K; Hann E; Barutcu A; Polat SD; ; Salerno M; Jerosch-Herold M; Kwong RY; Watkins HC; Kramer CM; Neubauer S; Ferreira VM; Piechnik SK
    Circulation; 2021 Aug; 144(8):589-599. PubMed ID: 34229451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction.
    Bai W; Xu R; Li X; Xu H; Fu H; Hou R; Zhou Z; Huang W; Wang Y; Guo Y
    BMC Cardiovasc Disord; 2022 Dec; 22(1):526. PubMed ID: 36474142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
    Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
    J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.